[
  {
    "ts": null,
    "headline": "BofA Lowers PT on Danaher Corporation (DHR) to $220 From $230",
    "summary": "Danaher Corporation (NYSE:DHR) is one of the best medical stocks to buy now. On September 22, BofA lowered the firm’s price target on Danaher Corporation (NYSE:DHR) to $220 from $230 while keeping a Buy rating on the shares. The firm told investors that although some trends are showing stabilization and/or improvement in certain areas of […]",
    "url": "https://finnhub.io/api/news?id=9c47a96b90dc2ab9f9f2d54bc96aaab83d808f73ab4ab26c6765415c20f73de6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759487269,
      "headline": "BofA Lowers PT on Danaher Corporation (DHR) to $220 From $230",
      "id": 136963257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE:DHR) is one of the best medical stocks to buy now. On September 22, BofA lowered the firm’s price target on Danaher Corporation (NYSE:DHR) to $220 from $230 while keeping a Buy rating on the shares. The firm told investors that although some trends are showing stabilization and/or improvement in certain areas of […]",
      "url": "https://finnhub.io/api/news?id=9c47a96b90dc2ab9f9f2d54bc96aaab83d808f73ab4ab26c6765415c20f73de6"
    }
  }
]